| Host species | Rabbit |
| Species reactivity | |
| Immunogen | Ranibizumab |
| Form | Liquid |
| Storage buffer | 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300. |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | ELISA |
| Target | Rabbit polyclonal to Lucentis. |
| Purification | Purified by antigen affinity column. |
| Stability and Storage | The product can be stored for 2 - 3 weeks at 2 to 8°C or for up to 12 months at -20°C. Avoid repeated freezing and thawing cycles. |
| Background | Ranibizumab with trade name Lucentis, is an FDA-approved drug for the treatment of patients with neovascular (Wet) age-related macular degeneration (AMD) and macular edema following retinal vein occlusion (RVO). It is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment. Ranibizumab binds to vascular endothelial growth factor A (VEGF-A) and blocks its activity. Antibodysystem Anti-Ranibizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Ranibizumab. |
| Alternative Names | |
| Note | Antibodysystem can customize this product per customer's request including product size, buffer components, etc. For research use only. |